Back

The Impact of Brexit on the Life Sciences Industry

Four Health Media, London, United Kingdom  
Thursday, November 08, 2018 12:30 AM - 3:30 AM   Add to Calendar Eastern Standard Time

Join HBA London and Four Health Media for a focused discussion on how Brexit will affect the UK Life Sciences industry based on the latest information available from October's EU Summit

The meeting is full and there is no waitlist available

HBA London presents

The Impact of Brexit on the Life Sciences Industry

Date and time
Thursday, 08 November
12:30AM - 03:30AM EST
Event Contact
Charlotte Leversha
07584275568
Competencies
12. Continues to learn, grow and transform
Event Sponsor

With less than six months to go until Britain's legal exit from the EU on 29 March 2019, and a no deal scenario very much still a possible outcome, life sciences companies need to have a plan in place accounting for every possibility. A no deal scenario would have a significant impact on both the EU and UK markets and may result in:

     • Medicines batch tested and released in the UK not able to be sold within the EU
     • Disruption to clinical trials due to issues with IMP or comparator product supply
     • Confusion over the status of EU nationals resulting in gap in healthcare staff
     • Delays in the delivery of raw materials and packaging causing stock outs of finished goods
     • If EMA approval not valid in UK, pharma companies may not seek approval in the UK for new drugs

Join HBA London, Four Health Media and a fantastic panel of speakers from across the industry for a focused discussion on how Brexit will affect the UK and EU life sciences industries.

Agenda
8:30 - 9:30 AM          Registration and networking over breakfast
9:30 - 11:00 AM        Brexit panel and Q & A
11:00 - 11:30 AM     Wrap up and networking

Special instructions: Closest station: London Bridge

Registration information
Event is open to: HBA members and nonmembers
Online registration deadline: 6 November 2018
Onsite (walk-in) registration: Is NOT allowed

This event is nonrefundable.

Featured Speakers

Angela  Bowden
Brexit lead for life sciences and consumer products
EY (Ernst & Young) - US
Leslie  Galloway
Chairman
EMIG
Sarah  Jones
Managing director
Four Health Public Affairs
Andrew  McConaghie
PME editor
Pharma Market Europe
Erik  Nordkamp
UK managing director
Pfizer Inc.
Learning Objectives
Hear about the current thinking on what impact Brexit will have on the UK and EU life sciences companies.

Registration information

The registration button at the bottom of the page will not show if online registration has closed or if the event has reached capacity. If you are a guest and the registration button is not showing, it may be that this is a member-only event. Read more about the benefits of membership or contact us about membership.

The HBA will make reasonable modifications to policies and programs to ensure that people with special needs have an equal opportunity to enjoy all of its programs. Contact us if you require special accommodations for this event.

 Price LevelRegular
Collapse group

Registration: Regular registration
 Member$30.00
 Member - Euro€26.00
 Non-Member$45.00
 Non-Member - Euro€39.00
The meeting is full and there is no waitlist available

By registering for this event, you acknowledge that you may be photographed, videotaped and/or audio-taped during the course of the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.